Cargando…
Survey of tumorigenic sensitivity in 6-month rasH2-Tg mice studies compared with 2-year rodent assays
The pharmacokinetic endpoint of a 25-fold increase in human exposure is one of the specified criteria for high-dose selection for 2-year carcinogenicity studies in rodents according to ICH S1C(R2). However, this criterion is not universally accepted for 6-month carcinogenicity tests in rasH2-Tg mice...
Autores principales: | Hisada, Shigeru, Tsubota, Kenjiro, Inoue, Kenji, Yamada, Hisaharu, Ikeda, Takanori, Sistare, Frank D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japanese Society of Toxicologic Pathology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828610/ https://www.ncbi.nlm.nih.gov/pubmed/35221496 http://dx.doi.org/10.1293/tox.2021-0031 |
Ejemplares similares
-
Primary epididymis squamous cell carcinoma in a CB6F1-Tg rasH2
mouse
por: Ikeda, Manabu, et al.
Publicado: (2022) -
Accumulation of Mott cells in the spleen in a CB6F1-Tg rasH2 mouse
por: Sano, Tomoya, et al.
Publicado: (2016) -
Immunohistochemical characterization of urethane-induced lung tumors in CB6F1-Tg rasH2 mice
por: Sano, Tomoya, et al.
Publicado: (2017) -
Progression process and safety assessment adaptation of endometrial lesions in ENU-induced 2-stage uterine carcinogenicity in a Tg-rasH2 mouse model
por: Kuroda, Hiroyuki, et al.
Publicado: (2017) -
Carcinogenicity evaluation for the application of carbon nanotubes as biomaterials in rasH2 mice
por: Takanashi, Seiji, et al.
Publicado: (2012)